SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO 1 Clinical Practice ...
The Colon Age tool estimates individualized colon age, aiding discussions on CRC screening needs and enhancing personalized care. Rising CRC rates in adults under 50 are linked to poor diet, obesity, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results